Navigation Links
MedImmune to present 4 abstracts on RSV and influenza at 47TH Annual IDSA Meeting
Date:10/30/2009

PHILADELPHIA, P.A., October 30, 2009 MedImmune announced today it will present four abstracts at the 47th Annual Meeting of Infectious Disease Society of America (IDSA) being held here October 29 through November 1, 2009. These abstracts advance the body of data surrounding respiratory syncytial virus (RSV) and influenza prevention, highlighting MedImmune's leadership in pediatric health.

"MedImmune is dedicated to conducting ground-breaking research on the prevention of respiratory syncytial virus (RSV) and influenza in children," said Alexander A. Zukiwski, M.D., executive vice president and chief medical officer. "We believe the data being presented at the conference may help advance innovative healthcare solutions for these important causes of respiratory infections in children."

MedImmune abstracts to be presented at IDSA on RSV include:

  • Prophylaxis Utilizing Nebulized Motavizumab, a Monoclonal Antibody Against Fusion Protein of Respiratory Syncytial Virus (RSV) Zhang J, et al. Poster Session: October 30, 2009; 12:30 2:00 PM; Poster Hall A / Poster # 608

    BACKGROUND: Respiratory syncytial virus (RSV) infection is the primary cause of pneumonia and bronchiolitis in young children, and also causes disease in older adults. This study evaluated the prophylactic use of nebulized motavizumab, an investigational anti-RSV humanized monoclonal antibody against RSV fusion protein, in cotton rats. The findings suggest that prophylaxis with nebulized motavizumab may inhibit RSV infection and spread in the lungs and may provide an alternative to the current intramuscular antibody delivery.

    MedImmune abstracts to be presented at IDSA on influenza include:

  • A Postmarketing Evaluation of the Frequency of Use and Safety of Live Attenuated Influenza Vaccine Use in Unapproved Children Less Than 59 Months of Age Tennis P, et al. Poster Session: October 31, 2009; 12:30-2:00 PM; Hall A / Poster #1179

    <
    '/>"/>

Contact: Tor Constantino
301-398-5801
Edelman Public Relations
Source:Eurekalert

0

GOOD

Page: 1 2 3

Related medicine news :

1. MedImmune to present data on RSV and influenza at 2009 AAP National Conference and Exhibition
2. MedImmune Receives U.S. Government Order for Additional 29 Million Doses of Nasal Spray Vaccine for 2009 H1N1 Influenza
3. Catalyst Biosciences Announces Agreement With MedImmune to Discover and Develop Engineered Protease Therapeutics
4. MedImmune Expands Access for Eligible Premature Infants to Receive Synagis(R) at No Cost
5. Medarex to Receive Milestone Payment from MedImmune for Allowance of an Investigational New Drug Application for MEDI-546
6. MedImmune grants 5 new fellowships to help expand premature infant follow-up care research
7. MedImmune Further Expands Autoimmune Disease Research Program Through Collaboration with SBI Biotech
8. MedImmune Prepared to Support Implementation of Expanded ACIP Recommendations for Influenza Vaccinations
9. MedImmune Expands Scientific and Engineering Leadership
10. Micromet and MedImmune to Present New Clinical Data for Anti-CD19 BiTE(R) Antibody at American Society of Hematology Annual Meeting Showing Objective Clinical Responses in Relapsed Non-Hodgkins Lymphoma Patients
11. MedImmune presents new pharmaco-economic data at AAP regarding infants at high risk for RSV
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... May 22, 2013 Zensah® Compression Apparel ... News article titled "Breast pain while running ... bras could help." According to the article, a ... a substantial amount suffer from breast pain while running ... correct the issue. , Zensah emphasizes the importance ...
(Date:5/22/2013)... 2013 People in the United States have ... water shortages. In much of the world, water shortages are ... Sharon Kleyne. She warns against taking water for granted and ... available so easily in the United States. , Sharon Kleyne ... radio show, heard live or by podcast on World Talk ...
(Date:5/22/2013)... IA (PRWEB) May 22, 2013 Diversity ... piece Handicap This! The performance promotes awareness that ... dreams. The Handicap This! performance will be held Friday, ... High School auditorium. Tickets for Handicap This! can ... This! helps audiences measure the level to which their ...
(Date:5/22/2013)... ARBORA University of Michigan study challenges previous research ... Baseball. , The study, a collaboration between researchers ... Florida, looks deeper into the controversial argument over ... strikes for pitchers of the same race. It ... said Jason Winfree, associate professor of sport management ...
(Date:5/22/2013)... that hospitals may be reaping enormous income for ... bloodstream infections contracted in their intensive care units. ... in the American Journal of Medical Quality ... who develops an avoidable central line-associated bloodstream infection ... for than a similar infection-free patient. Moreover, hospitals ...
Breaking Medicine News(10 mins):Health News:Zensah® Comments on New York Daily News Article Examining How Better Sports Bra Could Help Women Marathoners 2Health News:Zensah® Comments on New York Daily News Article Examining How Better Sports Bra Could Help Women Marathoners 3Health News:Water Advocate Sharon Kleyne Announces Water Conservation Appreciation 2Health News:Handicap This! Comes to Marion, Iowa 2Health News:U-M study challenges notion that umpires call more strikes for pitchers of same race 2Health News:Hospitals profit when patients develop bloodstream infections 2Health News:Hospitals profit when patients develop bloodstream infections 3Health News:Hospitals profit when patients develop bloodstream infections 4
... Light, or photodynamic, therapy can help preserve the ... stage laryngeal (voice box) cancer, according to a study ... is an effective treatment for early laryngeal squamous cell ... side effects than other therapies, while preserving the voice," ...
... HealthDay Reporter , FRIDAY, Jan. 28 (HealthDay News) -- ... pain exacerbated by lack of control -- with doctors poking ... grows near. Hospice care, however, can give back some ... treating pain and helping both the dying person and the ...
... researchers have come one step closer to understanding how ... many common drugs, including some antibiotics, antihistamines and anti-psychotics, ... is estimated around 40-50% of all drugs in development ... electricity in the heart and, as a result, can ...
... Reporter , FRIDAY, Jan. 28 (HealthDay News) -- Vailia Dennis says ... on anyone else,s timetable. Dennis, 91, of Rancho Bernardo, Calif., ... diagnosed with a fatal heart condition. At the time, she was ... heart condition that I have, is one that should have and ...
... News) -- Celiac disease and Crohn,s disease share several genetic ... makes it hard to absorb nutrients properly, is an inherited ... is damaged by gluten and other protein found in wheat ... inflammatory bowel disease. An international team of researchers conducted ...
... Morris Goodman Cancer Research Centre (GCRC), the Research Institute ... DanaFarber Cancer Institute and Harvard Medical School have discovered ... cancer patients are at risk of relapse, thereby sparing ... unnecessary treatment. For years, clinicians have been ...
Cached Medicine News:Health News:Voice-saver: Light therapy for early-stage laryngeal cancer 2Health News:Voice-saver: Light therapy for early-stage laryngeal cancer 3Health News:More People Choosing Hospice at Life's End 2Health News:More People Choosing Hospice at Life's End 3Health News:Victor Chang scientists unlock the 'gates' on sudden cardiac death 2Health News:Woman's Life Refutes a Hospice Myth 2
(Date:5/22/2013)... -- MEDIFIRST SOLUTIONS, INC. (OTCQB: MFST) would like to ... company developments. As Medifirst continues to expand its business, ... Integrating social media into its investor relations strategy, the ... updates on Twitter.  The Facebook homepage is Medifirst Solutions ... Says CEO Bruce J. Schoengood , ...
(Date:5/22/2013)... 22, 2013 Ranbaxy Laboratories Limited (hereafter, ... (hereafter, Daiichi Sankyo), announced on May 22 the ... to address past conduct under prior management ... Daiichi Sankyo continues to support Ranbaxy in its ... the past which led to the investigations by ...
(Date:5/22/2013)... Israel , May 22, 2013  Rosetta ... developer and provider of microRNA-based molecular diagnostics, announces that ... Chief Executive Officer of Rosetta Genomics, will deliver a ... place from June 3-6, 2013 in New York City.  ... 4 th at 2:00 p.m. Eastern time. ...
Breaking Medicine Technology:Medifirst Solutions, Inc. Announces Update To Shareholders 2Rosetta Genomics to Present at the Jefferies 2013 Healthcare Conference 2Rosetta Genomics to Present at the Jefferies 2013 Healthcare Conference 3
SOLOS Endoscopy shares your commitment to provide every patient with the highest quality care available through our ongoing research and development of advanced surgical instruments and diagnostic so...
SOLOS Endoscopy shares your commitment to provide every patient with the highest quality care available through our ongoing research and development of advanced surgical instruments and diagnostic so...
SOLOS Endoscopy shares your commitment to provide every patient with the highest quality care available through our ongoing research and development of advanced surgical instruments and diagnostic so...
... The Featured Products are ... Mediflex and are offered ... in regular or extra ... equipped with insulation, flush ...
Medicine Products: